These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 33139874)
1. Clinical features and clinical course of thyroid-associated ophthalmopathy: a case series of 3620 Chinese cases. Du B; Wang Y; Yang M; He W Eye (Lond); 2021 Aug; 35(8):2294-2301. PubMed ID: 33139874 [TBL] [Abstract][Full Text] [Related]
2. [Clinical Analysis of 2 170 Cases of Thyroid-Associated Ophthalmopathy Involving Extraocular Muscles]. Yang M; Du BX; Wang YJ; He WM Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 May; 52(3):510-515. PubMed ID: 34018373 [TBL] [Abstract][Full Text] [Related]
3. Clinical phenotypes of euthyroid, hyperthyroid, and hypothyroid thyroid-associated ophthalmopathy. Yang M; Wang Y; Du B; He W Graefes Arch Clin Exp Ophthalmol; 2023 Jul; 261(7):1995-2002. PubMed ID: 36806995 [TBL] [Abstract][Full Text] [Related]
4. [The value of DCE-MRI in assessing the course of thyroid associated ophthalmopathy]. Wu T; Tang DR; Wang F; Xia S; Sun FY Zhonghua Yan Ke Za Zhi; 2017 Jun; 53(6):430-435. PubMed ID: 28606264 [No Abstract] [Full Text] [Related]
5. Clinical features of thyroid-associated ophthalmopathy in clinically euthyroid Korean patients. Jang SY; Lee SY; Lee EJ; Yoon JS Eye (Lond); 2012 Sep; 26(9):1263-9. PubMed ID: 22744391 [TBL] [Abstract][Full Text] [Related]
6. Prevalence, Phenotype, and Psychosocial Well-Being in Euthyroid/Hypothyroid Thyroid-Associated Orbitopathy. Ponto KA; Binder H; Diana T; Matheis N; Otto AF; Pitz S; Pfeiffer N; Kahaly GJ Thyroid; 2015 Aug; 25(8):942-8. PubMed ID: 26244413 [TBL] [Abstract][Full Text] [Related]
7. Correlation between extent of lacrimal gland prolapse and clinical features of thyroid-associated ophthalmopathy: a retrospective observational study. Gao Y; Chang Q; Li Y; Zhang H; Hou Z; Zhang Z; Li Z; Li D BMC Ophthalmol; 2022 Feb; 22(1):66. PubMed ID: 35144579 [TBL] [Abstract][Full Text] [Related]
8. Treatment of Graves' disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: an open study. Salvi M; Vannucchi G; Campi I; Currò N; Dazzi D; Simonetta S; Bonara P; Rossi S; Sina C; Guastella C; Ratiglia R; Beck-Peccoz P Eur J Endocrinol; 2007 Jan; 156(1):33-40. PubMed ID: 17218723 [TBL] [Abstract][Full Text] [Related]
9. [Clinical analysis of 403 cases of thyroid associated ophthalmopathy]. Wang YJ; He WM Zhonghua Yan Ke Za Zhi; 2013 Aug; 49(8):685-90. PubMed ID: 24246805 [TBL] [Abstract][Full Text] [Related]
10. ROLE OF MAGNETIC RESONANCE IMAGING IN THE ASSESSMENT OF ACTIVE THYROID-ASSOCIATED OPHTHALMOPATHY PATIENTS WITH LONG DISEASE DURATION. Zhou M; Shen L; Jiao Q; Ye L; Zhou Y; Zhu W; Wang W; Wang S Endocr Pract; 2019 Dec; 25(12):1268-1278. PubMed ID: 31412229 [No Abstract] [Full Text] [Related]
11. Quantitative evaluation of activity of thyroid-associated Ophthalmopathy using short-tau inversion recovery (STIR) sequence. Ge Q; Zhang X; Wang L; Fan Y; Huang Q; Yao N; Long J; Liu C BMC Endocr Disord; 2021 Nov; 21(1):226. PubMed ID: 34774035 [TBL] [Abstract][Full Text] [Related]
12. Sun B; Zhang Z; Dong C; Zhang Y; Yan C; Li S; Eye (Lond); 2017 May; 31(5):668-676. PubMed ID: 28387769 [TBL] [Abstract][Full Text] [Related]
13. Correlation of clinical and radiological scores for evaluation of activity in patients having thyroid-associated orbitopathy: A prospective observational study. Singh M; Rana N; Ahuja C; Gupta P; Zadeng Z Indian J Ophthalmol; 2024 Jun; 72(6):844-848. PubMed ID: 38804801 [TBL] [Abstract][Full Text] [Related]
14. The significance of ophthalmological features in diagnosis of thyroid-associated ophthalmopathy. Huang X; Tang W; Shen Y; He L; Tong F; Liu S; Li J; Li P; Zhang Y; Ma X; Wei R; Yang W Biomed Eng Online; 2023 Feb; 22(1):7. PubMed ID: 36739403 [TBL] [Abstract][Full Text] [Related]
15. Age and gender influence on clinical manifestations of thyroid-associated ophthalmopathy: a case series of 2479 Chinese patients. Yang M; He W Front Endocrinol (Lausanne); 2024; 15():1434155. PubMed ID: 39421533 [TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance imaging and ultrasound measurements of extraocular muscles in thyroid-associated ophthalmopathy at different stages of the disease. Lennerstrand G; Tian S; Isberg B; Landau Högbeck I; Bolzani R; Tallstedt L; Schworm H Acta Ophthalmol Scand; 2007 Mar; 85(2):192-201. PubMed ID: 17305734 [TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance imaging with diffusion-weighted imaging in the evaluation of thyroid-associated orbitopathy: getting below the tip of the iceberg. Politi LS; Godi C; Cammarata G; Ambrosi A; Iadanza A; Lanzi R; Falini A; Bianchi Marzoli S Eur Radiol; 2014 May; 24(5):1118-26. PubMed ID: 24519110 [TBL] [Abstract][Full Text] [Related]
18. [Extraocular muscle involvement in patients with thyroid-associated orbitopathy]. Karhanová M; Kovář R; Fryšák Z; Zapletalová J; Marešová K; Sín M; Heřman M Cesk Slov Oftalmol; 2014 Apr; 70(2):66-71. PubMed ID: 25030316 [TBL] [Abstract][Full Text] [Related]
19. Assessment of the levels of interleukin-17 and interleukin-38 in thyroid-associated ophthalmopathy patients. Mussakulova A; Balmukhanova A; Aubakirova A; Zhunusova G; Balmukhanova A; Issakhanova J; Saliev T; Tanabayeva S; Fakhradiyev I Int Ophthalmol; 2023 Aug; 43(8):2811-2824. PubMed ID: 36894821 [TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics of moderate-to-severe thyroid associated ophthalmopathy in 354 Chinese cases. Li Q; Ye H; Ding Y; Chen G; Liu Z; Xu J; Chen R; Yang H PLoS One; 2017; 12(5):e0176064. PubMed ID: 28472149 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]